Aryl Phosphoramidates of 5-Phospho Erythronohydroxamic Acid, A New Class of Potent Trypanocidal Compounds
Open Access
- 28 July 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (16) , 6071-6078
Abstract
RNAi and enzymatic studies have shown the importance of 6-phosphogluconate dehydrogenase (6-PGDH) in Trypanosoma brucei for the parasite survival and make it an attractive drug target for the development of new treatments against human African trypanosomiasis. 2,3-O-Isopropylidene-4-erythrono hydroxamate is a potent inhibitor of parasite Trypanosoma brucei 6-phosphogluconate dehydrogenase (6-PGDH), the third enzyme of the pentose phosphate pathway. However, this compound does not have trypanocidal activity due to its poor membrane permeability. Consequently, we have previously reported a prodrug approach to improve the antiparasitic activity of this inhibitor by converting the phosphate group into a less charged phosphate prodrug. The activity of prodrugs appeared to be dependent on their stability in phosphate buffer. Here we have successfully further extended the development of the aryl phosphoramidate prodrugs of 2,3-O-isopropylidene-4-erythrono hydroxamate by synthesizing a small library of phosphoramidates and evaluating their biological activity and stability in a variety of assays. Some of the compounds showed high trypanocidal activity and good correlation of activity with their stability in fresh mouse blood.Keywords
This publication has 15 references indexed in Scilit:
- Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialThe Lancet, 2009
- Discovery of Phosphonic Diamide Prodrugs and Their Use for the Oral Delivery of a Series of Fructose 1,6-Bisphosphatase InhibitorsJournal of Medicinal Chemistry, 2008
- Prodrugs of Phosphates and PhosphonatesJournal of Medicinal Chemistry, 2008
- Selective Inhibition of Trypanosoma brucei 6-Phosphogluconate Dehydrogenase by High-Energy Intermediate and Transition-State AnaloguesJournal of Medicinal Chemistry, 2004
- Prodrugs of biologically active phosphate estersBioorganic & Medicinal Chemistry, 2003
- 2‐Nucleos‐5′‐O‐yl‐4H‐1,3,2‐benzodioxaphos‐phinin‐2‐oxides—A New Concept for Lipophilic, Potential Prodrugs of Biologically Active Nucleoside MonophosphatesAngewandte Chemie International Edition, 1996
- Increase of the anti-HIV activity of D4T in human T-cell culture by the use of the sate pronucleotide approachBioorganic & Medicinal Chemistry Letters, 1995
- Minireview: nucleotide prodrugsAntiviral Research, 1995
- Synthesis and Antitumor Evaluation of Bis[(pivaloyloxy)methyl] 2'-Deoxy-5-fluorouridine 5'-Monophosphate (FdUMP): A Strategy To Introduce Nucleotides into CellsJournal of Medicinal Chemistry, 1994
- Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZTJournal of Medicinal Chemistry, 1993